Annexon ANNX
NASDAQ ANNX
$4.85 +0.01 (+0.21%)
As of: Sep 4, 2026 · 3:20 PM EDT

Annexon (ANNX) Income towards Parent Company (2019 - 2026)

Annexon (ANNX) posted quarterly Income towards Parent Company of -$78.1 million for Q1 2026, down 9.25% year-over-year from -$86.0 million in Q1 2025, and down 15.75% quarter-over-quarter from -$67.4 million in Q4 2025.

Analysis

Annexon (ANNX) Income towards Parent Company (2019 - 2026) Analysis & Trends

Annexon's Income towards Parent Company history runs 8 years deep, the most recent figure standing at -$78.1 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company fell 9.25% year-over-year to -$78.1 million; the TTM figure through Mar 2026 stood at -$268.0 million (up 4.7% YoY), while the FY2025 annual figure was -$441.3 million, down 31.76% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$78.1 million, down from -$67.4 million in the prior quarter.
  • The five-year high for Income towards Parent Company was -$40.0 million in Q4 2022, with the low at -$160.9 million in Q4 2023.
  • The 5-year median for Income towards Parent Company is -$71.5 million (2025), against an average of -$74.2 million.
  • The sharpest annual moves came in 2023 and 2024: Income towards Parent Company sank 302.25% in 2023, then jumped 64.82% in 2024.
  • Annexon's Income towards Parent Company stood at -$40.0 million in 2022, then tumbled by 302.25% to -$160.9 million in 2023, then surged by 64.82% to -$56.6 million in 2024, then fell by 19.16% to -$67.4 million in 2025, then retreated by 15.75% to -$78.1 million in 2026.
  • Business Quant data shows ANNX's Income towards Parent Company at -$78.1 million in Q1 2026, -$67.4 million in Q4 2025, and -$62.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Annexon 974.87 Mn 974.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.23 Mn
Mar 31, 2026 -46.11 Mn
Dec 31, 2025 -50.21 Mn
Sep 30, 2025 -57.00 Mn
Jun 30, 2025 -51.73 Mn
Mar 31, 2025 -57.51 Mn
Dec 31, 2024 -52.54 Mn
Sep 30, 2024 -39.28 Mn
Jun 30, 2024 -33.57 Mn
Mar 31, 2024 -28.61 Mn
Dec 31, 2023 -29.95 Mn
Sep 30, 2023 -34.73 Mn
Jun 30, 2023 -37.64 Mn
Mar 31, 2023 -41.08 Mn
Dec 31, 2022 -36.67 Mn
Sep 30, 2022 -36.03 Mn
Jun 30, 2022 -37.47 Mn
Mar 31, 2022 -35.62 Mn
Dec 31, 2021 -37.56 Mn
Sep 30, 2021 -35.60 Mn